<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">FEMS Microbiol Lett</journal-id><journal-id journal-id-type="iso-abbrev">FEMS Microbiol Lett</journal-id><journal-id journal-id-type="publisher-id">femsle</journal-id><journal-title-group><journal-title>FEMS Microbiology Letters</journal-title></journal-title-group><issn pub-type="ppub">0378-1097</issn><issn pub-type="epub">1574-6968</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8195692</article-id><article-id pub-id-type="pmid">34057181</article-id><article-id pub-id-type="doi">10.1093/femsle/fnab060</article-id><article-id pub-id-type="publisher-id">fnab060</article-id><article-categories><subj-group subj-group-type="heading"><subject>Minireview</subject><subj-group subj-group-type="category-toc-heading"><subject>Biotechnology and Synthetic Biology</subject></subj-group></subj-group><subj-group subj-group-type="category-oup-series"><subject>Mini Review</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI01150</subject></subj-group></article-categories><title-group><article-title>Synthetic biology approaches to actinomycete strain improvement</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Breitling</surname><given-names>Rainer</given-names></name><aff>
<institution>Department of Chemistry, Manchester Institute of Biotechnology, Manchester Synthetic Biology Research Centre SYNBIOCHEM, The University of Manchester</institution>, 131 Princess Street, Manchester, M1 7DN, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Avbelj</surname><given-names>Martina</given-names></name><aff>
<institution>Biotechnical Faculty, University of Ljubljana</institution>, Jamnikarjeva 101, 1000 Ljubljana, <country country="SI">Slovenia</country></aff></contrib><contrib contrib-type="author"><name><surname>Bilyk</surname><given-names>Oksana</given-names></name><aff>
<institution>Department of Chemistry, Manchester Institute of Biotechnology, Manchester Synthetic Biology Research Centre SYNBIOCHEM, The University of Manchester</institution>, 131 Princess Street, Manchester, M1 7DN, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Carratore</surname><given-names>Francesco&#x000a0;Del</given-names></name><aff>
<institution>Department of Chemistry, Manchester Institute of Biotechnology, Manchester Synthetic Biology Research Centre SYNBIOCHEM, The University of Manchester</institution>, 131 Princess Street, Manchester, M1 7DN, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Filisetti</surname><given-names>Alessandro</given-names></name><aff>
<institution>Explora Biotech Srl, Doulix business unit</institution>, Via Torino 107, 30133 Venice, <country country="IT">Italy</country></aff></contrib><contrib contrib-type="author"><name><surname>Hanko</surname><given-names>Erik K R</given-names></name><aff>
<institution>Department of Chemistry, Manchester Institute of Biotechnology, Manchester Synthetic Biology Research Centre SYNBIOCHEM, The University of Manchester</institution>, 131 Princess Street, Manchester, M1 7DN, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Iorio</surname><given-names>Marianna</given-names></name><aff>
<institution>Naicons srl.</institution>, Viale Ortles 22/4, 20139 Milano, <country country="IT">Italy</country></aff></contrib><contrib contrib-type="author"><name><surname>Redondo</surname><given-names>Rosario P&#x000e9;rez</given-names></name><aff>
<institution>INBIOTEC Instituto de Biotecnolog&#x000ed;a de Le&#x000f3;n</institution>, Avenida Real 1, 24006 Le&#x000f3;n, <country country="ES">Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Reyes</surname><given-names>Fernando</given-names></name><aff>
<institution>Fundaci&#x000f3;n MEDINA, Centro de Excelencia en Investigaci&#x000f3;n de Medicamentos Innovadores en Andaluc&#x000ed;a, Avenida del Conocimiento 34, Parque Tecnologico de Ciencias de la Salud</institution>, 18016 Armilla, Granada, <country country="ES">Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Rudden</surname><given-names>Michelle</given-names></name><aff>
<institution>Department of Biology, University of York</institution>, Wentworth Way, York, YO10 5DD, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Severi</surname><given-names>Emmanuele</given-names></name><aff>
<institution>Department of Biology, University of York</institution>, Wentworth Way, York, YO10 5DD, <country country="GB">UK</country></aff><xref rid="afn1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name><surname>Slemc</surname><given-names>Lucija</given-names></name><aff>
<institution>Biotechnical Faculty, University of Ljubljana</institution>, Jamnikarjeva 101, 1000 Ljubljana, <country country="SI">Slovenia</country></aff></contrib><contrib contrib-type="author"><name><surname>Schmidt</surname><given-names>Kamila</given-names></name><aff>
<institution>Department of Chemistry, Manchester Institute of Biotechnology, Manchester Synthetic Biology Research Centre SYNBIOCHEM, The University of Manchester</institution>, 131 Princess Street, Manchester, M1 7DN, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Whittall</surname><given-names>Dominic R</given-names></name><aff>
<institution>Department of Chemistry, Manchester Institute of Biotechnology, Manchester Synthetic Biology Research Centre SYNBIOCHEM, The University of Manchester</institution>, 131 Princess Street, Manchester, M1 7DN, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Donadio</surname><given-names>Stefano</given-names></name><aff>
<institution>Naicons srl.</institution>, Viale Ortles 22/4, 20139 Milano, <country country="IT">Italy</country></aff></contrib><contrib contrib-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>Antonio Rodr&#x000ed;guez</given-names></name><aff>
<institution>INBIOTEC Instituto de Biotecnolog&#x000ed;a de Le&#x000f3;n</institution>, Avenida Real 1, 24006 Le&#x000f3;n, <country country="ES">Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Genilloud</surname><given-names>Olga</given-names></name><aff>
<institution>Fundaci&#x000f3;n MEDINA, Centro de Excelencia en Investigaci&#x000f3;n de Medicamentos Innovadores en Andaluc&#x000ed;a, Avenida del Conocimiento 34, Parque Tecnologico de Ciencias de la Salud</institution>, 18016 Armilla, Granada, <country country="ES">Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Kosec</surname><given-names>Gregor</given-names></name><aff>
<institution>Acies Bio d.o.o.</institution>, Tehnolo&#x00161;ki Park 21, 1000, Ljubljana, <country country="SI">Slovenia</country></aff></contrib><contrib contrib-type="author"><name><surname>De&#x000a0;Lucrezia</surname><given-names>Davide</given-names></name><aff>
<institution>Explora Biotech Srl, Doulix business unit</institution>, Via Torino 107, 30133 Venice, <country country="IT">Italy</country></aff></contrib><contrib contrib-type="author"><name><surname>Petkovi&#x00107;</surname><given-names>Hrvoje</given-names></name><aff>
<institution>Biotechnical Faculty, University of Ljubljana</institution>, Jamnikarjeva 101, 1000 Ljubljana, <country country="SI">Slovenia</country></aff></contrib><contrib contrib-type="author"><name><surname>Thomas</surname><given-names>Gavin</given-names></name><aff>
<institution>Department of Biology, University of York</institution>, Wentworth Way, York, YO10 5DD, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Takano</surname><given-names>Eriko</given-names></name><!--eriko.takano@manchester.ac.uk--><aff>
<institution>Department of Chemistry, Manchester Institute of Biotechnology, Manchester Synthetic Biology Research Centre SYNBIOCHEM, The University of Manchester</institution>, 131 Princess Street, Manchester, M1 7DN, <country country="GB">UK</country></aff><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><author-notes><corresp id="cor1">
<bold>Corresponding author:</bold> Department of Chemistry, Manchester Institute of Biotechnology, Manchester Synthetic Biology Research Centre SYNBIOCHEM, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. E-mail: <email>eriko.takano@manchester.ac.uk</email></corresp><fn id="afn1"><p>Present address: Biosciences Institute, Microbes in Health and Disease Theme, Newcastle University</p></fn></author-notes><pub-date pub-type="collection"><month>5</month><year>2021</year></pub-date><pub-date pub-type="epub" iso-8601-date="2021-05-31"><day>31</day><month>5</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>5</month><year>2021</year></pub-date><volume>368</volume><issue>10</issue><elocation-id>fnab060</elocation-id><history><date date-type="received"><day>17</day><month>3</month><year>2021</year></date><date date-type="accepted"><day>28</day><month>5</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021. Published by Oxford University Press on behalf of FEMS.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fnab060.pdf"/><abstract><title>ABSTRACT</title><p>Their biochemical versatility and biotechnological importance make actinomycete bacteria attractive targets for ambitious genetic engineering using the toolkit of synthetic biology. But their complex biology also poses unique challenges. This mini review discusses some of the recent advances in synthetic biology approaches from an actinomycete perspective and presents examples of their application to the rational improvement of industrially relevant strains.</p></abstract><abstract abstract-type="teaser"><p>Recent advances in synthetic biology driven engineering of the actinomycetes for the production of valuable drug compounds.</p></abstract><kwd-group kwd-group-type="keywords"><kwd>actinomycete</kwd><kwd>synthetic biology</kwd><kwd>actinobacteria</kwd><kwd>biosynthesis</kwd><kwd>biotechnology</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>European Union</institution><institution-id institution-id-type="DOI">10.13039/501100000780</institution-id></institution-wrap>
</funding-source><award-id>720793</award-id></award-group></funding-group><counts><page-count count="9"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>INTRODUCTION</title><p>Actinomycetes are chemically extremely talented bacteria, known for the exceptional diversity of their secondary metabolites (Barka <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib6" ref-type="bibr">2016</xref>; Jakubiec-Krzesniak <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib39" ref-type="bibr">2018</xref>). They are a major source for bioactive natural products, serving as starting points for clinically important drugs, in particular antibiotics (Genilloud <xref rid="bib27" ref-type="bibr">2017</xref>). Genome analyses show that individual strains of actinobacterial genomes typically contain the biosynthetic machinery for several dozen secondary metabolites, encoded in biosynthetic gene clusters in the genome ready for horizontal gene transfer as a compact functional unit (Lee <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib55" ref-type="bibr">2020</xref>). The emergence of advanced genome engineering techniques and the concepts and methodology of synthetic biology have stimulated renewed interest in exploiting the biosynthetic capabilities of actinomycetes, modifying and improving their performance as biotechnological sources of valuable drugs and drug precursors (Lee <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib57" ref-type="bibr">2019</xref>; Palazzotto <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib78" ref-type="bibr">2019</xref>; Zhao, Wang and Luo <xref rid="bib117" ref-type="bibr">2019</xref>). In this mini review, we highlight selected areas of synthetic biology as applied to actinomycete strain improvement. We focus on some areas of recent advances, as well as specific challenges encountered when engineering this specific group of microbes and offer an industrial perspective on the potential applications of synthetic biology to enhance the potential of actinobacteria as drug production hosts.</p></sec><sec id="sec2"><title>THE CHALLENGES OF HETEROLOGOUS EXPRESSION IN ACTINOMYCETES</title><p>Novel actinomycete strains, producing new compounds of interest with the potential of becoming industrial products, such as pharmaceuticals, crop-protecting agents or food additives are identified regularly (Onaka <xref rid="bib77" ref-type="bibr">2017</xref>; Kim <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib47" ref-type="bibr">2021</xref>). Initially, these novel strains of interest are not immediately used at an industrial scale, as their use presents several challenges due to a limited understanding of the strain and/or the product. The strain could have been identified after bioprospecting (Genilloud <xref rid="bib28" ref-type="bibr">2019</xref>; Nogawa, Lopez and Osada <xref rid="bib76" ref-type="bibr">2019</xref>) or after expression of a suitable DNA library (Zhang, Tang and Moore <xref rid="bib115" ref-type="bibr">2019</xref>). To translate the initial discovery into an industrial product, we need to study the producing strain and the biosynthetic pathway in considerable detail. The methods of synthetic biology are essential for this process. In particular, it is often necessary to genetically engineer the pathway or the host system by the introduction of heterologous genetic material.</p><p>Great progress has been made over the past decades in developing gene transfer systems for many actinomycete species and genera (Musiol-Kroll <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib73" ref-type="bibr">2019</xref>; Mitousis, Thoma and Musiol-Kroll <xref rid="bib72" ref-type="bibr">2020</xref>), and in devising effective genome editing tools (Alberti and Corre <xref rid="bib2" ref-type="bibr">2019</xref>). However, any actinomycete strain newly identified after bioprospecting is, by definition, poorly characterized and consequently often difficult to manipulate genetically. One can look at taxonomically related strains for inspiration; however, as a rule of thumb, developing a gene transfer system for a new strain is an unpredictable endeavor: successful introduction of heterologous DNA can either occur after a few months&#x02019; effort, or a whole year can go by without progress. Even after a gene transfer system has been developed for a model strain, the genetic tools available in the actinomycete community will need to be tested and validated in the new strain.</p><p>A conceptually attractive alternative to developing a gene transfer system is to rely on production of the desired product in a robust and easy to manipulate host, after heterologous expression of the necessary genes (Xu and Wright <xref rid="bib108" ref-type="bibr">2019</xref>; Kang and Kim <xref rid="bib44" ref-type="bibr">2021</xref>). This is a relatively straightforward approach that can benefit from a large selection of tools for introducing small and large segments in the host of choice (Tocchetti, Donadio and Sosio <xref rid="bib94" ref-type="bibr">2018</xref>), and successful heterologous expression can be confirmed relatively quickly. However, we still know very little about what controls formation of a heterologous product, from supply of precursors to enzymatic cofactors and from regulatory networks to efficient export of the final product. Consequently, heterologous expression of the native biosynthetic gene cluster (BGC) usually results in product titres lower than those obtained in the original host. These challenges necessitate a concerted approach at genetic engineering to optimize both the host production strain and the biosynthetic pathway itself for function in its new context.</p></sec><sec id="sec3"><title>PREDICTIVE MODELLING: METABOLISM AND BEYOND</title><p>Predictive metabolic modelling is a key ingredient in the rational engineering of improved production strains (Simeonidis and Price <xref rid="bib88" ref-type="bibr">2015</xref>). Such models can help identify competing metabolic pathways, optimal medium design and strategies for selecting high-producing mutants. Stoichiometric constraint-based models of metabolism have been particularly popular and successful for this purpose (Kim, Kim and Lee <xref rid="bib50" ref-type="bibr">2017</xref>; Gu <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib33" ref-type="bibr">2019</xref>), and multiple generations of increasingly refined and carefully curated models have been constructed for several important actinomycetes, including the model organisms <italic toggle="yes">Streptomyces coelicolor</italic> (Amara, Takano and Breitling <xref rid="bib4" ref-type="bibr">2018</xref>; Kumelj <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib53" ref-type="bibr">2019</xref>), <italic toggle="yes">S. lividans</italic> (D'Huys <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib22" ref-type="bibr">2012</xref>; Valverde, Gull&#x000f3;n and Mellado <xref rid="bib101" ref-type="bibr">2018</xref>), and the industrial producer <italic toggle="yes">S. clavuligerus</italic> (Medema <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib70" ref-type="bibr">2010</xref>; Toro <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib95" ref-type="bibr">2018</xref>). In each of these, the models have been used not only to understand the basic biology of metabolism, but also to identify targets for strain engineering (Kim, Rocha and Maia <xref rid="bib48" ref-type="bibr">2018</xref>).</p><p>The availability of well-curated reference models for different <italic toggle="yes">Streptomyces</italic> species has meant that this group could be employed as a benchmark for automated model reconstruction methods (Wang <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib102" ref-type="bibr">2018</xref>). Automated model reconstruction has rapidly expanded the range of actinomycetes for which genome-scale models are available. A large-scale comparative study of genome-scale metabolic models of 37 species of actinobacteria identified conserved core networks of metabolism (Alam <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib1" ref-type="bibr">2011</xref>). Comparative modelling simultaneously optimizing compound biosynthesis and biomass production has been employed to highlight the differences in metabolic capacity for selected classes of secondary metabolites in different potential actinomycete hosts (Zakrzewski <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib112" ref-type="bibr">2012</xref>). More recently, stoichiometric metabolic models have been complemented with enzyme level constraints to obtain more precise predictions of engineering strategies for enhanced secondary metabolite production in <italic toggle="yes">S. coelicolor</italic> (Sulheim <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib93" ref-type="bibr">2020</xref>).</p><p>Metabolic models are not only useful as stand-alone predictive tools, but are particularly powerful when combined with the results of molecular profiling experiments, such as transcriptome or metabolome profiling (Blazier and Papin <xref rid="bib10" ref-type="bibr">2012</xref>; Kleessen <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib51" ref-type="bibr">2015</xref>; Graudenzi <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib31" ref-type="bibr">2018</xref>). The MORF tool (Springthorpe <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib92" ref-type="bibr">2020</xref>) can facilitate this integration by providing a single platform for interrogating multi-omics data, e.g. transcriptomics and proteomics, and then using these data as additional constraints for a linked genome-scale metabolic model.</p><p>Stoichiometric models of metabolism can be constructed from genome sequences, with very limited requirements for experimental data. This allows their application even to organisms for which data availability limits more data-demanding modelling approaches. However, ensemble modelling strategies, which allow the construction of fully parameterized kinetic models of biological systems in the absence of extensive experimental data (Tsigkinopoulou, Baker and Breitling <xref rid="bib97" ref-type="bibr">2017</xref>; Tsigkinopoulou <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib98" ref-type="bibr">2018</xref>), are now making it possible to model additional aspects of actinomycete biology. For example, ensemble modeling has been employed for a detailed analysis of the &#x003b3;-butyrolactone network in <italic toggle="yes">S. coelicolor</italic> (Tsigkinopoulou, Takano and Breitling <xref rid="bib99" ref-type="bibr">2020</xref>), a system with exciting potential as an engineered regulatory circuit to control secondary metabolic pathways (Biarnes-Carrera <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib8" ref-type="bibr">2018</xref>; Biarnes-Carrera, Breitling and Takano <xref rid="bib7" ref-type="bibr">2018</xref>).</p></sec><sec id="sec4"><title>REGULATORY ENGINEERING: SRNA AS AN EMERGING TOOL</title><p>Successful engineering of secondary metabolite production requires regulatory tools (Xia <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib107" ref-type="bibr">2020</xref>; Zhou, Ning and Luo <xref rid="bib118" ref-type="bibr">2020</xref>), which so far have not been extensively studied in actinomycetes, compared to traditional model organisms. For example, in <italic toggle="yes">Streptomyces</italic> or other antibiotic-producing actinomycetes only a few sRNA studies have been related to secondary metabolism. However, there has been much recent progress, making new regulatory tools accessible to actinomycete synthetic biologists. In <italic toggle="yes">S. coelicolor</italic>, an antisense RNA, Cnc2198.1, was found in the 5&#x02019; region of the glutamine synthetase I gene <italic toggle="yes">glnA</italic>. The controlled overexpression of this antisense RNA resulted in a decrease in growth, protein synthesis and undecylprodigiosin production (D'Alia <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib21" ref-type="bibr">2010</xref>). Another sRNA, Scr4677, is encoded in the intergenic antisense strand between two co-transcribed regulatory genes (SCO4676 and SCO4677). Whilst disruption of each regulatory gene affected actinorhodin production, modulating Scr4677 levels showed no reproducible phenotypic differences (Hindra <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib35" ref-type="bibr">2014</xref>). Mikul&#x000ed;k <italic toggle="yes">et&#x000a0;al</italic>. (<xref rid="bib71" ref-type="bibr">2014</xref>) found that deletion of <italic toggle="yes">ssrS</italic> gene in <italic toggle="yes">S. coelicolor</italic>, encoding the conserved 6S RNA which binds the &#x003b2; and &#x003b2;&#x02019; subunits of RNA polymerase, reduced both the growth rate and actinorhodin production, which was accompanied by a lower expression of the pathway-specific <italic toggle="yes">actII</italic>-ORF4 transcriptional regulator (Mikul&#x000ed;k <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib71" ref-type="bibr">2014</xref>). Using RNA-seq, Liu <italic toggle="yes">et&#x000a0;al</italic>. (<xref rid="bib62" ref-type="bibr">2013</xref>) identified four sRNAs that were overexpressed in an industrial erythromycin-producing strain of <italic toggle="yes">Saccharopolyspora erythraea</italic> compared to the wild type strain (Liu <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib62" ref-type="bibr">2013</xref>). These genes are encoded on the complementary DNA strands of annotated ORFs, indicating a regulatory effect on iron transport (<italic toggle="yes">sernc293</italic>), terpene metabolism (<italic toggle="yes">sernc350</italic>), geosmin synthesis (<italic toggle="yes">sernc351</italic>) and polyketide biosynthesis (<italic toggle="yes">sernc389</italic>).</p><p>These fundamental advances are very promising for future applications, but few studies of sRNA-based regulatory engineering have been published in bacteria producing secondary metabolites of industrial interest (Chaudhary, Na and Lee <xref rid="bib17" ref-type="bibr">2015</xref>). In <italic toggle="yes">Streptomyces</italic>, the paired termini antisense (PTas)RNA strategy has been successfully applied to downregulate an actinorhodin biosynthetic gene in <italic toggle="yes">S. coelicolor</italic> (Uguru <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib100" ref-type="bibr">2013</xref>), to enhance antibiotic production through the inhibition of the transcriptional repressor DoxR in <italic toggle="yes">Streptomyces peucetius</italic> (Chaudhary <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib18" ref-type="bibr">2015a</xref>) and to elucidate the regulatory role of the cyclic AMP receptor protein (Crp) in <italic toggle="yes">Streptomyces cinnamonensis</italic> by comparing the monensin yields and transcriptomic profiles between control, <italic toggle="yes">crp</italic>-overexpressing and <italic toggle="yes">crp</italic>-silencing strains (Lin <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib60" ref-type="bibr">2020</xref>). There is a pressing need for more extensive studies to identify sRNAs and elucidate their function in <italic toggle="yes">Streptomyces</italic> and other actinomycetes with a rich secondary metabolism.</p></sec><sec id="sec5"><title>CLONING, REFACTORING AND ASSEMBLY OF COMPLEX METABOLIC PATHWAYS</title><p>The biosynthetic capabilities of actinomycetes are encoded in large and complex BGCs. Successful strain engineering depends on our ability to manipulate these clusters efficiently, and a wide array of <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic> methods have been established for this purpose. <italic toggle="yes">In vivo</italic> DNA assembly methods are based on the natural homologous recombination capacity in <italic toggle="yes">Saccharomyces cerevisiae</italic> or the Red/ET homologous recombination system. Transformation-associated recombination (TAR) cloning in yeast has been successfully employed to capture and heterologously express a range of natural product BGCs, including those of taromycin A, enterocin, greocycline and cosmomycin (Yamanaka <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib109" ref-type="bibr">2014</xref>; Bonet <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib11" ref-type="bibr">2015</xref>; Bilyk <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib9" ref-type="bibr">2016</xref>; Larson, Cr&#x000fc;semann and Moore <xref rid="bib54" ref-type="bibr">2017</xref>). In a study by Eyles, Vior and Truman (<xref rid="bib24" ref-type="bibr">2018</xref>), an integrated approach of TAR and yeast-mediated engineering was used to refactor the bottromycin BGC from <italic toggle="yes">Streptomyces scabies</italic>. After capturing the <italic toggle="yes">btm</italic> cluster in a yeast/<italic toggle="yes">Escherichia coli</italic> shuttle vector using TAR, yeast-mediated homologous recombination was employed to assemble a variety of pathway combinations using PCR products, single stranded oligonucleotides and individual pathway fragments generated by restriction digestion. This approach allowed for the simultaneous introduction of promoters, gene deletions, targeted mutations and rearrangement of gene order, yielding a refactored BGC with a 120-fold increase in bottromycin-related metabolites in the heterologous host <italic toggle="yes">S. coelicolor</italic> (Eyles, Vior and Truman <xref rid="bib24" ref-type="bibr">2018</xref>).</p><p>Recently, a TAR-based and CRISPR/Cas9-mediated promoter engineering platform, termed multiplex <italic toggle="yes">in vitro</italic> Cas9-TAR (<italic toggle="yes">mi</italic>CASTAR), has been developed by Kim, Rocha and Maia (<xref rid="bib48" ref-type="bibr">2018</xref>) for the activation of the silent atolypenes BGC from <italic toggle="yes">Amycolatopsis tolypomycina</italic>. Following this approach, the <italic toggle="yes">ato</italic> cluster was digested <italic toggle="yes">in vitro</italic> by Cas9, reassembled in yeast using promoter cassettes with homology arms matching the specific Cas9 digestion sites and introduced into <italic toggle="yes">Streptomyces albus</italic> (Kim, Rocha and Maia <xref rid="bib48" ref-type="bibr">2018</xref>). Similar to TAR in yeast, the Red/ET homologous recombination system can be employed for assembly of complex BGCs in <italic toggle="yes">E. coli</italic>. Using Red/ET recombination, a variety of semi-synthetic promoters was incorporated into the bottromycin BGC, increasing the production titre by up to 50-fold (Horbal <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib36" ref-type="bibr">2018</xref>).</p><p>Examples of successful <italic toggle="yes">in vitro</italic> assembly methods include Gibson assembly, site-specific recombination-based tandem assembly (SSRTA) and methylation-assisted tailorable ends rational (MASTER) ligation (Zhang, Zhao and Ding <xref rid="bib116" ref-type="bibr">2011</xref>; Shao <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib87" ref-type="bibr">2013</xref>; Linares-Otoya <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib61" ref-type="bibr">2017</xref>). Gibson assembly is often coupled to <italic toggle="yes">in vitro</italic> applications of gene editing techniques for synthetic biology driven investigations. For example, a 36-kb jadomycin producing gene cluster from <italic toggle="yes">Streptomyces venezuelae</italic> was successfully cloned into an <italic toggle="yes">E. coli</italic> vector via Cas9-assisted targeting of chromosome segments (CATCH). RNA-guided Cas9 nuclease cleaves the target chromosome at two designated sites, prior to insertion of the target genome segment into a cloning vector by Gibson assembly. However, heterologous production of jadomycin was not reported (Jiang <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib41" ref-type="bibr">2015</xref>). In a similar manner, Li <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib59" ref-type="bibr">(2017</xref>) effectively combined the CRISPR/Cas9 system with Gibson assembly to incorporate the pristinamycin II (PII) BGC into <italic toggle="yes">Streptomyces pristinaespiralis</italic>; the resulting strain produced the highest titres of PII yet reported.</p><p>Direct pathway cloning (DiPaC), a combination of long-amplicon PCR and <italic toggle="yes">in vitro</italic> DNA recombination, successfully transplanted the native erythromycin BGC into a <italic toggle="yes">Streptomyces</italic> host for heterologous expression, with production confirmed via HPLC-MS (Greunke <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib32" ref-type="bibr">2018</xref>).</p><p>In addition, <italic toggle="yes">in vitro</italic> assembly methods can also be applied in the refactoring of biosynthetic pathways for the optimized production of valuable natural products in actinomycetes. Song <italic toggle="yes">et al</italic>. (<xref rid="bib91" ref-type="bibr">2019</xref>) utilized the ExoCET (Exonuclease combined with RecET recombination) method to construct a plasmid containing a 79&#x000a0;kb artificial, GC-rich cluster for the heterologous production of insecticide spinosad within <italic toggle="yes">S. albus</italic> J1074.</p><p>Often, molecular engineering tools developed in other model organisms do not immediately work when applied in actinobacteria. Ye <italic toggle="yes">et&#x000a0;al</italic>. (<xref rid="bib110" ref-type="bibr">2020</xref>) present an example, showing how the fine-tuning of Cas9 expression is essential to obtain good performance of a CRISPR/Cas9 system in several <italic toggle="yes">Streptomyces</italic> species.</p></sec><sec id="sec6"><title>MANIPULATION OF PRODUCT EFFLUX FOR INCREASING YIELDS</title><p>While synthetic biology approaches have been used successfully in the engineering of metabolic pathways, resulting in bacteria that can produce high titres or novel products, the final step in the biosynthesis pathway, namely the export of the product into extracellular medium, is often overlooked, despite product efflux being a highly effective step to manipulate to increase yields in whole-cell catalysts (Kell <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib46" ref-type="bibr">2015</xref>; Lv <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib65" ref-type="bibr">2016</xref>; Soares-Silva <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib90" ref-type="bibr">2020</xref>). Most natural product BGCs in actinomycetes contain transporter genes of one type or another and their functions are almost exclusively involved in efflux, either in the secretion of the newly synthesized compound itself or in subsequent self-protection of the producing cell (Mart&#x000ed;n, Casqueiro and Liras <xref rid="bib67" ref-type="bibr">2005</xref>). Compared to the enzymatic machinery involved in the biosynthesis of natural products, the efflux proteins are rarely studied and only few examples of characterized systems are available, which have recently been reviewed in detail (Severi and Thomas <xref rid="bib86" ref-type="bibr">2019</xref>).</p><p>The simplest approach to empirically improve efflux/export is to overexpress the gene for the transporter. The streptogramin family of antibiotics provide the first example of this method, with pristinamycin produced by <italic toggle="yes">Streptomyces pristinaespiralis</italic>. The overexpression of a known resistance gene, <italic toggle="yes">ptr</italic>, that encodes an efflux pump of the major facilitator superfamily (MFS) resulted in 6 to 8-fold increase in yield of the antibiotic (Jin, Jin and Jin <xref rid="bib43" ref-type="bibr">2010</xref>). In a second example the production of the macrocyclic polyketide avermectin was also improved by about 50% by overexpression of the BGC-encoded ATP-binding cassette (ABC) transporter genes <italic toggle="yes">avtAB</italic> (Qiu <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib81" ref-type="bibr">2011</xref>). A third example comes from the production of oxytetracycline in <italic toggle="yes">Streptomyces rimosus</italic>, where the wild-type strain was modified to overexpress its three known self-resistance/export genes, of which two encode efflux proteins, and this resulted in oxytetracycline yields increasing over 150% (Yin <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib111" ref-type="bibr">2017</xref>).</p><p>Applying a synthetic biology approach to improve this process requires the ability to access or create variants of suitable transporter genes and apply an effective and simple high-throughput screen to assess function. An early approach of this kind was taken to try and build on the success of overexpressing <italic toggle="yes">ptr</italic> for increased pristinamycin production, where a DNA shuffling method was used to create a library of hybrid <italic toggle="yes">ptr</italic> genes taken from different high-producing strains of <italic toggle="yes">S. pristinaespiralis</italic> (Jin <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib42" ref-type="bibr">2015</xref>). However, this strategy resulted in strains producing highly variable antibiotic yields with none of the hybrids surpassing the performance of the original Ptr protein, suggesting that larger libraries of random point mutants and/or Ptr homologues from different <italic toggle="yes">Streptomyces</italic> species, such as the <italic toggle="yes">varS/snbR</italic> gene from the virginiamycin biosynthetic cluster (Mast <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib69" ref-type="bibr">2011</xref>; Severi and Thomas <xref rid="bib86" ref-type="bibr">2019</xref>) would be more successful.</p><p>In an excellent example of the evolutionary approach, random mutagenesis has been used to evolve a transporter with an expanded substrate range for a biotechnological application (Bali, Genee and Sommer <xref rid="bib5" ref-type="bibr">2018</xref>). In this work, the function of a vitamin transporter unable to take up thiamine was linked to a growth-coupled biosensor that consisted of a thiamine-responsive riboswitch silencing a selectable marker. As the starting transporter cannot import thiamine, the riboswitch represses the marker and cells die on selective medium, thus providing a powerful genetic screen for gain-of-function mutants by growth on selective media. By screening a library of 60&#x000a0;000 variants made by error-prone PCR on this single transporter, the authors successfully found a transporter with the desired properties. Elegant screens of this nature could be used in the context of evolving antibiotic exporters with different affinities and specificities or just increased capacity for antibiotic export. Synthetic biology approaches can be used to create these candidate parts, and in this regard the <italic toggle="yes">Streptomyces</italic> genus provides an enormous reservoir of potential antibiotic exporter genes, with many genomes encoding around 1000 different transporters (around 10% of total coding capacity; Ren, Chen and Paulsen <xref rid="bib83" ref-type="bibr">2007</xref>; Zhou <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib120" ref-type="bibr">2016</xref>). It is highly likely that many of these function as either specific or multi-drug exporters to provide cross-resistance to natural products produced by other species in the complex soil niche, and synthetic biology methods now enable this enormous pool of untapped transporters to be sampled, characterized and exploited.</p></sec><sec id="sec7"><title>MOLECULAR PROFILING FOR ACTINOMYCETE SYNTHETIC BIOLOGY</title><p>Synthetic biology relies on the availability of molecular diagnostic tools for the analysis of the function of an engineered biological system. In the case of actinomycete synthetic biology, which largely focuses on the production of secondary metabolites, metabolomics is often the method of choice for this purpose. It can be applied in two major directions: either for the characterization of metabolic changes across the entire system, including primary metabolism, or to identify and quantify secondary metabolites and their precursors in a more targeted approach.</p><p>For example, a recent study on the impact of the expression of the actinorhodin BGC on the metabolome of <italic toggle="yes">S. coelicolor</italic> found pervasive effects across the metabolic network, including changes in precursors of secondary metabolites, as the result of the activity of a single biosynthetic pathway (Nitta <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib74" ref-type="bibr">2021</xref>). Quantitative analysis of the metabolome of <italic toggle="yes">S. nodosus</italic> allowed the rational engineering of improved amphotericin B production strains (Zhang <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib114" ref-type="bibr">2020</xref>).</p><p>Ideally, metabolomics is combined with other molecular profiling methods, e.g. measuring transcriptome dynamics and metabolic effects simultaneously. In actinomycete synthetic biology, such multi-omics analyses have a long tradition (Zhou <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib119" ref-type="bibr">2011</xref>; Lee <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib56" ref-type="bibr">2021</xref>), ranging from delimiting dispensable regions in <italic toggle="yes">Streptomyces</italic> genomes (Bu <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib13" ref-type="bibr">2020</xref>) and understanding the dynamic physiology of growth underlying the induction of secondary metabolite production (Kim <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib49" ref-type="bibr">2020</xref>), to understanding the effect of extracellular cAMP as a regulator of secondary metabolite production (Nitta <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib75" ref-type="bibr">2020</xref>).</p><p>Engineered actinomycetes rarely are exclusive producers of the target chemical. More often, they co-produce relatively complex mixtures of secondary metabolites, creating additional analytical challenges for metabolomics profiling. Recent advances in LC-MS based approaches and tools for the fast identification of natural products, such as Global Natural Products Social molecular networking (GNPS) have revolutionized natural product research (Wang <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib103" ref-type="bibr">2016</xref>). Yet, the challenge remains of annotating the spectral information and identifying detected metabolites by linking isotopic patterns and fragmentation data to given molecular structures in secondary metabolites databases (Allard, Genta-Jouve and Wolfender <xref rid="bib3" ref-type="bibr">2017</xref>; Caesar <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib15" ref-type="bibr">2019</xref>). In the case of comprehensive metabolome profiles, Bayesian methods that take into account the plausible biochemical relationships among the ingredients of a sample can add further support to the annotation process&#x02014;and provide a principled statistical assessment of the confidence in individual identifications (Tripathi <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib96" ref-type="bibr">2021</xref>).</p><p>Despite considerable advances, the structural elucidation of co-produced natural products remains a complex process leading in some cases to the assignment of incorrect structures. Computer Assisted Structural Elucidation (CASE) approaches, both commercial and academic, have been developed as powerful tools to help in the process through the generation of prioritized structural proposals, although these applications provide only planar (2D) structures and further improvements are still required to determine 3D structures (Burns, Mazzola and Reynolds <xref rid="bib14" ref-type="bibr">2019</xref>). Moreover, the DP4-AI software has emerged as a tool complementary to CASE for completely automated 3D structural elucidation starting from raw <sup>13</sup>C and <sup>1</sup>H NMR data (Howarth, Ermanis and Goodman <xref rid="bib37" ref-type="bibr">2020</xref>). Apart from these tools, databases including calculated/real NMR data and NMR structural features easily recognizable in NMR spectra have been developed to speed up the structural elucidation of new compounds and were reviewed recently (P&#x000e9;rez-Victoria, Mart&#x000ed;n and Reyes <xref rid="bib79" ref-type="bibr">2016</xref>).</p><p>Since then, other approaches based on the use of NMR in combination with structural features obtained from fast NMR experiments (Zani and Carroll <xref rid="bib113" ref-type="bibr">2017</xref>) or 2D heteronuclear single quantum coherence (HSQC) NMR spectra in combination with MS or <sup>1</sup>H NMR data have been developed. Perhaps the most remarkable effort in this sense has been the Small Molecule Accurate Recognition Technology (SMART) initiative (Reher <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib82" ref-type="bibr">2020</xref>). Using the HSQC spectrum of a sample as a query, this Artificial Intelligence-based tool allows the generation of structural hypotheses by comparative analysis with a library of&#x000a0;&#x0003e;&#x000a0;100,000&#x000a0;real or computed spectra of natural products. The system also includes external links to other platforms including mass spectrometry, BGC and structural information in cases where known natural products are identified: GNPS, MiBIG (Kautsar <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib45" ref-type="bibr">2020</xref>) and the Natural Products Atlas (Van Santen <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib84" ref-type="bibr">2019</xref>). Lately, <sup>13</sup>C NMR-based tools have also been developed to dereplicate compounds in mixtures (MixONat; Brugui&#x000e8;re <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib12" ref-type="bibr">2020</xref>) or the prediction of natural product classes (Mart&#x000ed;nez-Trevi&#x000f1;o <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib68" ref-type="bibr">2020</xref>).</p></sec><sec id="sec8"><title>APPLICATION CASE 1: CHALLENGES OF TETRACYCLINE PRODUCTION</title><p>The native tetracycline (TC) producing strains <italic toggle="yes">Streptomyces aureofaciens</italic> and <italic toggle="yes">S. rimosus</italic> are powerful industrial producers of chlortetracycline (CTC) and oxytetracycline (OTC), respectively, aromatic polyketide metabolites of medical and agricultural importance (Chopra and Roberts <xref rid="bib19" ref-type="bibr">2001</xref>). Industrial strains for the production of these valuable compounds have been developed over many decades by intensive mutagenesis and strain selection approaches (Goodman <xref rid="bib30" ref-type="bibr">1985</xref>). The main challenge today is to further improve the yield of target TCs, particularly by increasing the rate of conversion of the carbon source, mostly from media containing starch, while reducing the presence of undesired impurities. OTC-producing <italic toggle="yes">S. rimosus</italic> strains are generally easily transformable, fast-growing strains compared to many other streptomycetes and numerous industrially useful molecular biology tools and microbiology methods are available, including the latest genome editing technologies, which make these strains attractive chassis for a synthetic biology approach (Jia <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib40" ref-type="bibr">2017</xref>; Carrillo Rinc&#x000f3;n <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib16" ref-type="bibr">2018</xref>).</p><p>Early successes were realized when a chlortetracycline BGC was heterologously expressed in the industrial strain <italic toggle="yes">S. rimosus</italic> 461, and additional engineering to achieve overexpression of a cluster-situated activator led to 38-fold increase in titre of CTC compared to the original producer (Wang <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib106" ref-type="bibr">2019</xref>). There is at present a critical need for novel antibiotics, to address the rapid spread of antibacterial resistance, and TC intermediates and shunt products may represent a very attractive source of drug leads (Martens and Demain <xref rid="bib66" ref-type="bibr">2017</xref>; Petkovi&#x00107;, Luke&#x0017e;i&#x0010d; and &#x00160;u&#x00161;kovi&#x00107; <xref rid="bib80" ref-type="bibr">2017</xref>). Because of the rapid development of synthetic biology approaches, it is now possible to generate novel TC scaffolds through rational approaches (Wang <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib105" ref-type="bibr">2012</xref>; Cummings, Breitling and Takano <xref rid="bib20" ref-type="bibr">2014</xref>; Luke&#x0017e;i&#x0010d; <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib64" ref-type="bibr">2019</xref>). An important successful example is provided by the work of Wang <italic toggle="yes">et&#x000a0;al</italic>. (<xref rid="bib105" ref-type="bibr">2012</xref>) who used three structurally diverse natural tetracycline BGCs encoding antibiotic OTC, the antitumor SF2575 and dactylocycline as the starting point for engineering. A number of new tetracycline compounds were obtained from the engineered host-pathway pairs (Wang <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib105" ref-type="bibr">2012</xref>). Another example is the introduction of a novel starter unit into the backbone of the atypical tetracycline chelocardin produced by <italic toggle="yes">Amycolatopsis sulphurea</italic>, which results in a potent antibacterial compound currently in preclinical evaluation (Le&#x00161;nik <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib58" ref-type="bibr">2015</xref>).</p><p>However, it is becoming clear that polyketide synthase (PKS) enzymatic complexes catalysing the formation of TCs are not very robust, i.e. even a small modification of the targeted enzyme(s) may inhibit the catalytic activity of these complex enzymes, consequently disabling the functionality of the entire PKS complex. Most often, this results in a significant drop in the titres of target intermediate(s) or even in a derailment of the whole Type II PKS complex. Moreover, we have not yet completely elucidated the preferred order of the enzymatic reactions, particularly those related to the late stages in TC biosynthesis (post-PKS biosynthesis), when functional groups are added to the basic polyketide backbone (Wang <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib104" ref-type="bibr">2013</xref>). To fully capitalize on the potential of synthetic biology for improved and diversified tetracycline production, there is a need for more in-depth understanding of the catalytic mechanisms of the enzyme complexes involved.</p></sec><sec id="sec9"><title>APPLICATION CASE 2: PRODUCING RIPPS</title><p>Ribosomally synthesized and posttranslationally modified peptides (RIPPs) are one of the major groups of bioactive compounds found in actinomycetes. Because of its well-studied genetic background and a plethora of available molecular tools for strain engineering, <italic toggle="yes">S. coelicolor</italic> is one of the most frequently used hosts for heterologous expression of RiPP BGCs. Thiostreptamide S4, which belongs to a class of structurally novel RiPPs characterized by a contiguous sequence of thioamide groups, was originally isolated from <italic toggle="yes">Streptomyces</italic> sp. NRRL S-4 and heterologously produced in <italic toggle="yes">S. coelicolor</italic> M1146 at levels comparable to the native producer (Frattaruolo <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib26" ref-type="bibr">2017</xref>). Similarly, thiovarsolins, a second class of thioamidated RiPPs, were discovered in the genetically intractable <italic toggle="yes">S. varsoviensis</italic> and heterologously produced in <italic toggle="yes">S. coelicolor</italic> M1146 (Santos-Aberturas <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib85" ref-type="bibr">2019</xref>). In case of the leepeptin BGC from <italic toggle="yes">S. leeuwenhoekii</italic> C34T, constitutive expression of the BGC in the heterologous host <italic toggle="yes">S. coelicolor</italic> was necessary for sufficient quantities of leepeptin for enabling structural elucidation (Gomez-Escribano <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib29" ref-type="bibr">2019</xref>).</p><p>Aside from <italic toggle="yes">S. coelicolor</italic>, a variety of RiPP-encoding BGCs have been successfully expressed in other heterologous <italic toggle="yes">Streptomyces</italic> hosts in recent years. Using heterologous expression, it was possible to increase production of MS-271 18-fold and confirm that epimerization of the C-terminal L-tryptophan into its D-form involves a novel, uncharacterized epimerase (Feng <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib25" ref-type="bibr">2018</xref>). <italic toggle="yes">S. lividans</italic> TK24 has been also employed to produce a library of natural and designed derivatives of thioviridamide/neothioviridamide, an anti-cancer agent of RiPPs origin with polythioamide backbone. A total of eight of the designed molecules exhibit cytotoxicity twice that of the wild-type natural product (Kudo <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib52" ref-type="bibr">2019</xref>). Derivatization of the RiPP cinnamycin was achieved by incorporation of three noncanonical amino acid residues into two different positions of the core peptide. The methodology was developed using <italic toggle="yes">S. albus</italic> as a heterologous host via co-expression of the <italic toggle="yes">cin</italic> BGC and <italic toggle="yes">pyl</italic>RS/tRNA<sup>Pyl</sup> pair. In <italic toggle="yes">S. albus</italic>, the titre of deoxycinnamycin produced was 5-fold greater relative to the natural mixture of cinnamycins produced by the same heterologous host (Lopatniuk, Myronovskyi and Luzhetskyy <xref rid="bib63" ref-type="bibr">2017</xref>).</p><p>As the metabolic engineering of actinomycetes is frequently challenging, heterologous expression in <italic toggle="yes">E. coli</italic> is an important tool when probing the mechanisms of RiPP biosynthesis pathways derived from actinomycetes (Hwang <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib38" ref-type="bibr">2014</xref>). For example, a recent study investigating the installation of azole rings within the sulfomycin biosynthesis pathway of <italic toggle="yes">S. viridochromogenes</italic> employed <italic toggle="yes">E. coli</italic> as part of a heterologous expression strategy to examine the roles of a number of key residues within the core peptide of precursor peptide, SulA (Du <italic toggle="yes">et&#x000a0;al</italic>. <xref rid="bib23" ref-type="bibr">2020</xref>). In addition, the characterization of a novel venezuelin-like lanthipeptide was enabled by the establishment of an <italic toggle="yes">E. coli</italic>-based heterologous production system. Consequently, the study provided greater insight into the mechanism of class IV lanthipeptide biosynthesis (Hegemann and Van Der Donk <xref rid="bib34" ref-type="bibr">2018</xref>). The discovery of a unique two-component lantibiotic, roseocin, was in part facilitated by the partial <italic toggle="yes">in vitro</italic> reconstitution of the cluster within <italic toggle="yes">E. coli</italic>. The resulting posttranslationally modified lanthipeptides (RosA1 and RosA2) obtained from heterologous expression within <italic toggle="yes">E. coli</italic> were subsequently converted into bioactive roseocin via <italic toggle="yes">in vitro</italic> cleavage using commercial proteases (Singh, Chaudhary and Sareen <xref rid="bib89" ref-type="bibr">2020</xref>).</p></sec><sec sec-type="conclusions" id="sec10"><title>CONCLUSION</title><p>The recent great technological advances in the area of synthetic biology of actinomycetes present a great promise for a revolutionary transformation of the biotechnological production of powerful new drugs. They can facilitate the biochemical characterization of new compounds, help enhance their production to economically viable levels, support the chemical diversification of initial chemical scaffolds, and accelerate the transfer of new compounds to industrial production. The examples discussed illustrate the range of the techniques and concepts that contribute to this technological revolution, but they also highlight the numerous areas that still require further research before the full potential of synthetic biology can be realized. Actinomycetes, with their immense chemical diversity and their unique challenges and opportunities for biosynthetic engineering, will remain at the forefront of these developments.</p></sec></body><back><ack id="ack1"><title>ACKNOWLEDGEMENTS</title><p>This review was funded through the European Union's Horizon 2020 Research and Innovation Programme under grant agreement number 720793 TOPCAPI&#x02014;thoroughly Optimized Production Chassis for Advanced Pharmaceutical Ingredients. We would also like to acknowledge the support of all the partners and researchers in the TOPCAPI consortium in the research reviewed here.</p><p>Rainer Breitling, 0000&#x02013;0001&#x02013;7173&#x02013;0922; Martina Avbelj, 0000&#x02013;0001&#x02013;8677&#x02013;2332; Oksana Bilyk, 0000&#x02013;0002&#x02013;8159&#x02013;8088; Francesco Del Carratore, 0000&#x02013;0003&#x02013;1647&#x02013;7818; Alessandro Filisetti, 0000&#x02013;0002&#x02013;6389&#x02013;1109; Erik Hanko, 0000&#x02013;0002&#x02013;2850&#x02013;7773; Marianna Iorio, 0000&#x02013;0001&#x02013;8669&#x02013;5875; Rosario P&#x000e9;rez Redondo, 0000&#x02013;0002&#x02013;8782&#x02013;8796; Fernando Reyes, 0000&#x02013;0003&#x02013;1607&#x02013;5106; Michelle Rudden, 0000&#x02013;0001&#x02013;9617&#x02013;087X; Emmanuele Severi, 0000&#x02013;0001&#x02013;9750&#x02013;5539; Lucija Slemc, 0000&#x02013;0002&#x02013;8868&#x02013;734X; Kamila Schmidt, 0000&#x02013;0002&#x02013;7763&#x02013;1500; Dominic Whittall, 0000&#x02013;0001&#x02013;6176&#x02013;1872; Stefano Donadio, 0000&#x02013;0002&#x02013;2121&#x02013;8979; Antonio Rodr&#x000ed;guez Garc&#x000ed;a, 0000&#x02013;0001&#x02013;8118&#x02013;9762; Olga Genilloud, 0000&#x02013;0002&#x02013;4202&#x02013;1219; Gregor Kosec, 0000&#x02013;0003&#x02013;1370&#x02013;3728; Davide De Lucrezia, 0000&#x02013;0002&#x02013;2561&#x02013;1022; Hrvoje Petkovi&#x00107;, 0000&#x02013;0003&#x02013;1377&#x02013;9845; Gavin Thomas, 0000&#x02013;0002&#x02013;9763&#x02013;1313 and Eriko Takano 0000&#x02013;0002&#x02013;6791&#x02013;3256.</p></ack><sec sec-type="conflict" id="sec11"><title>Conflicts of Interest</title><p>None declared.</p></sec><ref-list id="ref1"><title>REFERENCES</title><ref id="bib1"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Alam</surname>
<given-names>MT</given-names>
</string-name>, <string-name><surname>Medema</surname><given-names>MH</given-names></string-name>, <string-name><surname>Takano</surname><given-names>E</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Comparative genome-scale metabolic modeling of actinomycetes: the topology of essential core metabolism</article-title>. <source>FEBS Lett</source>. <year>2011</year>;<volume>585</volume>:<fpage>2389</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">21712033</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Alberti</surname>
<given-names>F</given-names>
</string-name>, <string-name><surname>Corre</surname><given-names>C</given-names></string-name></person-group>. <article-title>Editing streptomycete genomes in the CRISPR/Cas9 age</article-title>. <source>Nat Prod Rep</source>. <year>2019</year>;<volume>36</volume>:<fpage>1237</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">30680376</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Allard</surname>
<given-names>PM</given-names>
</string-name>, <string-name><surname>Genta-Jouve</surname><given-names>G</given-names></string-name>, <string-name><surname>Wolfender</surname><given-names>JL</given-names></string-name></person-group>. <article-title>Deep metabolome annotation in natural products research: towards a virtuous cycle in metabolite identification</article-title>. <source>Curr Opin Chem Biol</source>. <year>2017</year>;<volume>36</volume>:<fpage>40</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">28088695</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Amara</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Takano</surname><given-names>E</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R</given-names></string-name></person-group>. <article-title>Development and validation of an updated computational model of <italic toggle="yes">Streptomyces coelicolor</italic> primary and secondary metabolism</article-title>. <source>BMC Genomics</source>. <year>2018</year>;<volume>19</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">29291715</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bali</surname>
<given-names>AP</given-names>
</string-name>, <string-name><surname>Genee</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Sommer</surname><given-names>MOA</given-names></string-name></person-group>. <article-title>Directed evolution of membrane transport using synthetic selections</article-title>. <source>ACS Synthetic Biol</source>. <year>2018</year>;<volume>7</volume>:<fpage>789</fpage>&#x02013;<lpage>93</lpage>.</mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Barka</surname>
<given-names>EA</given-names>
</string-name>, <string-name><surname>Vatsa</surname><given-names>P</given-names></string-name>, <string-name><surname>Sanchez</surname><given-names>L</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Taxonomy, physiology, and natural products of actinobacteria</article-title>. <source>Microbiol Mol Biol Rev</source>. <year>2016</year>;<volume>80</volume>:<fpage>1</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">26609051</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Biarnes-Carrera</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Breitling</surname><given-names>R</given-names></string-name>, <string-name><surname>Takano</surname><given-names>E</given-names></string-name></person-group>. <article-title>Detection and quantification of butyrolactones from streptomyces</article-title>. <source>Methods Mol Biol</source>. <year>2018</year>;<volume>1673</volume>:<fpage>117</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">29130169</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Biarnes-Carrera</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Lee</surname><given-names>CK</given-names></string-name>, <string-name><surname>Nihira</surname><given-names>T</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Orthogonal regulatory circuits for <italic toggle="yes">Escherichia coli</italic> based on the &#x003b3;-butyrolactone system of <italic toggle="yes">Streptomyces coelicolor</italic></article-title>. <source>ACS Synthetic Biol</source>. <year>2018</year>;<volume>7</volume>:<fpage>1043</fpage>&#x02013;<lpage>55</lpage>.</mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bilyk</surname>
<given-names>O</given-names>
</string-name>, <string-name><surname>Sekurova</surname><given-names>ON</given-names></string-name>, <string-name><surname>Zotchev</surname><given-names>SB</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Cloning and heterologous expression of the grecocycline biosynthetic gene cluster</article-title>. <person-group person-group-type="editor"><string-name><surname>Virolle</surname><given-names>M-J</given-names></string-name></person-group> (ed.). <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>:<fpage>e0158682</fpage>.<pub-id pub-id-type="pmid">27410036</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blazier</surname>
<given-names>AS</given-names>
</string-name>, <string-name><surname>Papin</surname><given-names>JA</given-names></string-name></person-group>. <article-title>Integration of expression data in genome-scale metabolic network reconstructions</article-title>. <source>Front Physiol</source>. <year>2012</year>;<volume>3</volume>:<fpage>299</fpage>.<pub-id pub-id-type="pmid">22934050</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bonet</surname>
<given-names>B</given-names>
</string-name>, <string-name><surname>Teufel</surname><given-names>R</given-names></string-name>, <string-name><surname>Cr&#x000fc;semann</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Direct capture and heterologous expression of salinispora natural product genes for the biosynthesis of enterocin</article-title>. <source>J Nat Prod</source>. <year>2015</year>;<volume>78</volume>:<fpage>539</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">25382643</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Brugui&#x000e8;re</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Derbr&#x000e9;</surname><given-names>S</given-names></string-name>, <string-name><surname>Dietsch</surname><given-names>J</given-names></string-name><etal>et al.</etal></person-group>
<article-title>MixONat, a software for the dereplication of mixtures based on 13C NMR spectroscopy</article-title>. <source>Anal Chem</source>. <year>2020</year>;<volume>92</volume>:<fpage>8793</fpage>&#x02013;<lpage>801</lpage>.<pub-id pub-id-type="pmid">32479074</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bu</surname>
<given-names>QT</given-names>
</string-name>, <string-name><surname>Li</surname><given-names>YP</given-names></string-name>, <string-name><surname>Xie</surname><given-names>H</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Comprehensive dissection of dispensable genomic regions in Streptomyces based on comparative analysis approach</article-title>. <source>Microb Cell Fact</source>. <year>2020</year>;<volume>19</volume>, <comment>DOI: 10.1186/s12934-020-01359-4</comment>.</mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Burns</surname>
<given-names>DC</given-names>
</string-name>, <string-name><surname>Mazzola</surname><given-names>EP</given-names></string-name>, <string-name><surname>Reynolds</surname><given-names>WF</given-names></string-name></person-group>. <article-title>The role of computer-assisted structure elucidation (CASE) programs in the structure elucidation of complex natural products</article-title>. <source>Nat Prod Rep</source>. <year>2019</year>;<volume>36</volume>:<fpage>919</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">30994691</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Caesar</surname>
<given-names>LK</given-names>
</string-name>, <string-name><surname>Kellogg</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Kvalheim</surname><given-names>OM</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Opportunities and limitations for untargeted mass spectrometry metabolomics to identify biologically active constituents in complex natural product mixtures</article-title>. <source>J Nat Prod</source>. <year>2019</year>;<volume>82</volume>:<fpage>469</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">30844279</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Carrillo&#x000a0;Rinc&#x000f3;n</surname>
<given-names>AF</given-names>
</string-name>, <string-name><surname>Magdevska</surname><given-names>V</given-names></string-name>, <string-name><surname>Kranjc</surname><given-names>L</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Production of extracellular heterologous proteins in <italic toggle="yes">Streptomyces rimosus</italic>, producer of the antibiotic oxytetracycline</article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2018</year>;<volume>102</volume>:<fpage>2607</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">29417200</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chaudhary</surname>
<given-names>AK</given-names>
</string-name>, <string-name><surname>Na</surname><given-names>D</given-names></string-name>, <string-name><surname>Lee</surname><given-names>EY</given-names></string-name></person-group>. <article-title>Rapid and high-throughput construction of microbial cell-factories with regulatory noncoding RNAs</article-title>. <source>Biotechnol Adv</source>. <year>2015</year>;<volume>33</volume>:<fpage>914</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">26027891</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chaudhary</surname>
<given-names>AK</given-names>
</string-name>, <string-name><surname>Pokhrel</surname><given-names>AR</given-names></string-name>, <string-name><surname>Hue</surname><given-names>NT</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Paired-termini antisense RNA mediated inhibition of DoxR in <italic toggle="yes">Streptomyces peucetius</italic> ATCC 27952</article-title>. <source>Biotechnol Bioprocess Eng</source>. <year>2015a</year>;<volume>20</volume>:<fpage>381</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chopra</surname>
<given-names>I</given-names>
</string-name>, <string-name><surname>Roberts</surname><given-names>M</given-names></string-name></person-group>. <article-title>Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance</article-title>. <source>Microbiol Mol Biol Rev</source>. <year>2001</year>;<volume>65</volume>:<fpage>232</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">11381101</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cummings</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Breitling</surname><given-names>R</given-names></string-name>, <string-name><surname>Takano</surname><given-names>E</given-names></string-name></person-group>. <article-title>Steps towards the synthetic biology of polyketide biosynthesis</article-title>. <source>FEMS Microbiol Lett</source>. <year>2014</year>;<volume>351</volume>:<fpage>116</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">24372666</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>D'Alia</surname>
<given-names>D</given-names>
</string-name>, <string-name><surname>Nieselt</surname><given-names>K</given-names></string-name>, <string-name><surname>Steigele</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Noncoding RNA of glutamine synthetase I modulates antibiotic production in <italic toggle="yes">Streptomyces coelicolor</italic> A3(2)</article-title>. <source>J Bacteriol</source>. <year>2010</year>;<volume>192</volume>:<fpage>1160</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">19966003</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>D'Huys</surname>
<given-names>PJ</given-names>
</string-name>, <string-name><surname>Lule</surname><given-names>I</given-names></string-name>, <string-name><surname>Vercammen</surname><given-names>D</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Genome-scale metabolic flux analysis of <italic toggle="yes">Streptomyces lividans</italic> growing on a complex medium</article-title>. <source>J Biotechnol</source>. <year>2012</year>;<volume>161</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">22641041</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Du</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Qiu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Meng</surname><given-names>X</given-names></string-name><etal>et al.</etal></person-group>
<article-title>A heterotrimeric dehydrogenase complex functions with 2 distinct YcaO proteins to install 5 azole heterocycles into 35-membered sulfomycin thiopeptides</article-title>. <source>J Am Chem Soc</source>. <year>2020</year>;<volume>142</volume>:<fpage>8454</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">32293883</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Eyles</surname>
<given-names>TH</given-names>
</string-name>, <string-name><surname>Vior</surname><given-names>NM</given-names></string-name>, <string-name><surname>Truman</surname><given-names>AW</given-names></string-name></person-group>. <article-title>Rapid and robust yeast-mediated pathway refactoring generates multiple new bottromycin-related metabolites</article-title>. <source>ACS Synthetic Biol</source>. <year>2018</year>;<volume>7</volume>:<fpage>1211</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Feng</surname>
<given-names>Z</given-names>
</string-name>, <string-name><surname>Ogasawara</surname><given-names>Y</given-names></string-name>, <string-name><surname>Nomura</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Biosynthetic gene cluster of a d-tryptophan-containing lasso peptide, MS-271</article-title>. <source>ChemBioChem</source>. <year>2018</year>;<volume>19</volume>:<fpage>2045</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">29974638</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Frattaruolo</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Lacret</surname><given-names>R</given-names></string-name>, <string-name><surname>Cappello</surname><given-names>AR</given-names></string-name><etal>et al.</etal></person-group>
<article-title>A genomics-based approach identifies a thioviridamide-like compound with selective anticancer activity</article-title>. <source>ACS Chem Biol</source>. <year>2017</year>;<volume>12</volume>:<fpage>2815</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">28968491</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Genilloud</surname>
<given-names>O</given-names>
</string-name>
</person-group>. <article-title>Actinomycetes: still a source of novel antibiotics</article-title>. <source>Nat Prod Rep</source>. <year>2017</year>;<volume>34</volume>:<fpage>1203</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">28820533</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Genilloud</surname>
<given-names>O</given-names>
</string-name>
</person-group>. <article-title>Natural products discovery and potential for new antibiotics</article-title>. <source>Curr Opin Microbiol</source>. <year>2019</year>;<volume>51</volume>:<fpage>81</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">31739283</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gomez-Escribano</surname>
<given-names>JP</given-names>
</string-name>, <string-name><surname>Castro</surname><given-names>JF</given-names></string-name>, <string-name><surname>Razmilic</surname><given-names>V</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Heterologous expression of a cryptic gene cluster from <italic toggle="yes">Streptomyces leeuwenhoekii</italic> C34T yields a novel lasso peptide, leepeptin</article-title>. <source>Appl Environ Microbiol</source>. <year>2019</year>;<volume>85</volume>, <comment>DOI: 10.1128/AEM.01752-19</comment>.</mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Goodman</surname>
<given-names>JJ</given-names>
</string-name>
</person-group>. <source>Fermentation and Mutational Development of the Tetracyclines</source>. <publisher-name>Springer</publisher-name>, <publisher-loc>Berlin, Heidelberg</publisher-loc>, <year>1985</year>, <fpage>5</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Graudenzi</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Maspero</surname><given-names>D</given-names></string-name>, <string-name><surname>Di&#x000a0;Filippo</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power</article-title>. <source>J Biomed Inform</source>. <year>2018</year>;<volume>87</volume>:<fpage>37</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">30244122</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Greunke</surname>
<given-names>C</given-names>
</string-name>, <string-name><surname>Duell</surname><given-names>ER</given-names></string-name>, <string-name><surname>D'Agostino</surname><given-names>PM</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Direct Pathway Cloning (DiPaC) to unlock natural product biosynthetic potential</article-title>. <source>Metab Eng</source>. <year>2018</year>;<volume>47</volume>:<fpage>334</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">29548983</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gu</surname>
<given-names>C</given-names>
</string-name>, <string-name><surname>Kim</surname><given-names>GB</given-names></string-name>, <string-name><surname>Kim</surname><given-names>WJ</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Current status and applications of genome-scale metabolic models</article-title>. <source>Genome Biol</source>. <year>2019</year>;<volume>20</volume>:<fpage>1</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">30606230</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hegemann</surname>
<given-names>JD</given-names>
</string-name>, <string-name><surname>Van&#x000a0;Der&#x000a0;Donk</surname><given-names>WA</given-names></string-name></person-group>. <article-title>Investigation of substrate recognition and biosynthesis in class IV lanthipeptide systems</article-title>. <source>J Am Chem Soc</source>. <year>2018</year>;<volume>140</volume>:<fpage>5743</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">29633842</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name name-style="given-only">
<given-names>Hindra</given-names>
</string-name>, <string-name><surname>Moody</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Jones</surname><given-names>SE</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Complex intra-operonic dynamics mediated by a small RNA in <italic toggle="yes">Streptomyces coelicolor</italic></article-title>. <person-group person-group-type="editor"><string-name><surname>Hoskisson</surname><given-names>P</given-names></string-name></person-group> (ed.). <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>:<fpage>e85856</fpage>.<pub-id pub-id-type="pmid">24465751</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Horbal</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Marques</surname><given-names>F</given-names></string-name>, <string-name><surname>Nadmid</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Secondary metabolites overproduction through transcriptional gene cluster refactoring</article-title>. <source>Metab Eng</source>. <year>2018</year>;<volume>49</volume>:<fpage>299</fpage>&#x02013;<lpage>315</lpage>.<pub-id pub-id-type="pmid">30240601</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Howarth</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Ermanis</surname><given-names>K</given-names></string-name>, <string-name><surname>Goodman</surname><given-names>JM</given-names></string-name></person-group>. <article-title>DP4-AI automated NMR data analysis: straight from spectrometer to structure</article-title>. <source>Chem Sci</source>. <year>2020</year>;<volume>11</volume>:<fpage>4351</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">34122893</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hwang</surname>
<given-names>KS</given-names>
</string-name>, <string-name><surname>Kim</surname><given-names>HU</given-names></string-name>, <string-name><surname>Charusanti</surname><given-names>P</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Systems biology and biotechnology of Streptomyces species for the production of secondary metabolites</article-title>. <source>Biotechnol Adv</source>. <year>2014</year>;<volume>32</volume>:<fpage>255</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">24189093</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jakubiec-Krzesniak</surname>
<given-names>K</given-names>
</string-name>, <string-name><surname>Rajnisz-Mateusiak</surname><given-names>A</given-names></string-name>, <string-name><surname>Guspiel</surname><given-names>A</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Secondary metabolites of actinomycetes and their antibacterial, antifungal and antiviral properties</article-title>. <source>Pol J Microbiol</source>. <year>2018</year>;<volume>67</volume>:<fpage>259</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">30451442</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jia</surname>
<given-names>H</given-names>
</string-name>, <string-name><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name><surname>Wang</surname><given-names>T</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Development of a crispr/cas9-mediated gene-editing tool in streptomyces rimosus</article-title>. <source>Microbiol (United Kingdom)</source>. <year>2017</year>;<volume>163</volume>:<fpage>1148</fpage>&#x02013;<lpage>55</lpage>.</mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jiang</surname>
<given-names>W</given-names>
</string-name>, <string-name><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name><surname>Gabrieli</surname><given-names>T</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Cas9-assisted targeting of chromosome segments CATCH enables one-step targeted cloning of large gene clusters</article-title>. <source>Nat Commun</source>. <year>2015</year>;<volume>6</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jin</surname>
<given-names>QC</given-names>
</string-name>, <string-name><surname>Shen</surname><given-names>N</given-names></string-name>, <string-name><surname>Yin</surname><given-names>H</given-names></string-name><etal>et al.</etal></person-group>
<article-title>DNA shuffling of ptr resistance gene leads to improved pristinamycin production in <italic toggle="yes">Streptomyces pristinaespiralis</italic></article-title>. <source>Mol Biol</source>. <year>2015</year>;<volume>49</volume>:<fpage>253</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jin</surname>
<given-names>Z</given-names>
</string-name>, <string-name><surname>Jin</surname><given-names>X</given-names></string-name>, <string-name><surname>Jin</surname><given-names>Q</given-names></string-name></person-group>. <article-title>Conjugal transferring of resistance gene ptr for improvement of pristinamycin-producing <italic toggle="yes">Streptomyces pristinaespiralis</italic></article-title>. <source>Appl Biochem Biotechnol</source>. <year>2010</year>;<volume>160</volume>:<fpage>1853</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">19629757</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kang</surname>
<given-names>HS</given-names>
</string-name>, <string-name><surname>Kim</surname><given-names>ES</given-names></string-name></person-group>. <article-title>Recent advances in heterologous expression of natural product biosynthetic gene clusters in Streptomyces hosts</article-title>. <source>Curr Opin Biotechnol</source>. <year>2021</year>;<volume>69</volume>:<fpage>118</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">33445072</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kautsar</surname>
<given-names>SA</given-names>
</string-name>, <string-name><surname>Blin</surname><given-names>K</given-names></string-name>, <string-name><surname>Shaw</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group>
<article-title>MIBiG 2.0: a repository for biosynthetic gene clusters of known function</article-title>. <source>Nucleic Acids Res</source>. <year>2020</year>;<volume>48</volume>:<fpage>D454</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">31612915</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kell</surname>
<given-names>DB</given-names>
</string-name>, <string-name><surname>Swainston</surname><given-names>N</given-names></string-name>, <string-name><surname>Pir</surname><given-names>P</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Membrane transporter engineering in industrial biotechnology and whole cell biocatalysis</article-title>. <source>Trends Biotechnol</source>. <year>2015</year>;<volume>33</volume>:<fpage>237</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">25746161</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kim</surname>
<given-names>JH</given-names>
</string-name>, <string-name><surname>Lee</surname><given-names>N</given-names></string-name>, <string-name><surname>Hwang</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture</article-title>. <source>J Ind Microbiol Biotechnol</source>. <year>2021</year>, <comment>DOI: 10.1093/jimb/kuaa001</comment>.</mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kim</surname>
<given-names>OD</given-names>
</string-name>, <string-name><surname>Rocha</surname><given-names>M</given-names></string-name>, <string-name><surname>Maia</surname><given-names>P</given-names></string-name></person-group>. <article-title>A review of dynamic modeling approaches and their application in computational strain optimization for metabolic engineering</article-title>. <source>Front Microbiol</source>. <year>2018</year>;<volume>9</volume>:<fpage>1690</fpage>.<pub-id pub-id-type="pmid">30108559</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kim</surname>
<given-names>W</given-names>
</string-name>, <string-name><surname>Hwang</surname><given-names>S</given-names></string-name>, <string-name><surname>Lee</surname><given-names>N</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Transcriptome and translatome profiles of Streptomyces species in different growth phases</article-title>. <source>Sci Data</source>. <year>2020</year>;<volume>7</volume>, <comment>DOI: 10.1038/s41597-020-0476-9</comment>.</mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kim</surname>
<given-names>WJ</given-names>
</string-name>, <string-name><surname>Kim</surname><given-names>HU</given-names></string-name>, <string-name><surname>Lee</surname><given-names>SY</given-names></string-name></person-group>. <article-title>Current state and applications of microbial genome-scale metabolic models</article-title>. <source>Curr Opin Syst Biol</source>. <year>2017</year>;<volume>2</volume>:<fpage>10</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kleessen</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Irgang</surname><given-names>S</given-names></string-name>, <string-name><surname>Klie</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Integration of transcriptomics and metabolomics data specifies the metabolic response of Chlamydomonas to rapamycin treatment</article-title>. <source>Plant J</source>. <year>2015</year>;<volume>81</volume>:<fpage>822</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">25600836</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kudo</surname>
<given-names>K</given-names>
</string-name>, <string-name><surname>Koiwai</surname><given-names>H</given-names></string-name>, <string-name><surname>Kagaya</surname><given-names>N</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Comprehensive derivatization of thioviridamides by heterologous expression</article-title>. <source>ACS Chem Biol</source>. <year>2019</year>;<volume>14</volume>:<fpage>1135</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">31184470</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kumelj</surname>
<given-names>T</given-names>
</string-name>, <string-name><surname>Sulheim</surname><given-names>S</given-names></string-name>, <string-name><surname>Wentzel</surname><given-names>A</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Predicting strain engineering strategies using iKS1317: a genome-scale metabolic model of <italic toggle="yes">Streptomyces coelicolor</italic></article-title>. <source>Biotechnol J</source>. <year>2019</year>;<volume>14</volume>:<fpage>1800180</fpage>.</mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Larson</surname>
<given-names>CB</given-names>
</string-name>, <string-name><surname>Cr&#x000fc;semann</surname><given-names>M</given-names></string-name>, <string-name><surname>Moore</surname><given-names>BS</given-names></string-name></person-group>. <article-title>PCR-independent method of transformation-associated recombination reveals the cosmomycin biosynthetic gene cluster in an ocean streptomycete</article-title>. <source>J Nat Prod</source>. <year>2017</year>;<volume>80</volume>:<fpage>1200</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">28333450</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname>
<given-names>N</given-names>
</string-name>, <string-name><surname>Hwang</surname><given-names>S</given-names></string-name>, <string-name><surname>Kim</surname><given-names>J</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Mini review: genome mining approaches for the identification of secondary metabolite biosynthetic gene clusters in Streptomyces</article-title>. <source>Comput Struct Biotechnol J</source>. <year>2020</year>;<volume>18</volume>:<fpage>1548</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">32637051</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname>
<given-names>N</given-names>
</string-name>, <string-name><surname>Hwang</surname><given-names>S</given-names></string-name>, <string-name><surname>Kim</surname><given-names>W</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Systems and synthetic biology to elucidate secondary metabolite biosynthetic gene clusters encoded in Streptomyces genomes</article-title>. <source>Nat Prod Rep</source>. <year>2021</year>, <comment>DOI: 10.1039/d0np00071j</comment>.</mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname>
<given-names>N</given-names>
</string-name>, <string-name><surname>Hwang</surname><given-names>S</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Synthetic biology tools for novel secondary metabolite discovery in streptomyces</article-title>. <source>J Microbiol Biotechnol</source>. <year>2019</year>;<volume>29</volume>:<fpage>667</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">31091862</pub-id></mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Le&#x00161;nik</surname>
<given-names>U</given-names>
</string-name>, <string-name><surname>Luke&#x0017e;i&#x0010d;</surname><given-names>T</given-names></string-name>, <string-name><surname>Podgor&#x00161;ek</surname><given-names>A</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering</article-title>. <source>Angew Chem</source>. <year>2015</year>;<volume>127</volume>:<fpage>4009</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Zheng</surname><given-names>G</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Multiplexed site-specific genome engineering for overproducing bioactive secondary metabolites in actinomycetes</article-title>. <source>Metab Eng</source>. <year>2017</year>;<volume>40</volume>:<fpage>80</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">28088540</pub-id></mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Linares-Otoya</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Linares-Otoya</surname><given-names>V</given-names></string-name>, <string-name><surname>Armas-Mantilla</surname><given-names>L</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Identification and heterologous expression of the kocurin biosynthetic gene cluster</article-title>. <source>Microbiol (United Kingdom)</source>. <year>2017</year>;<volume>163</volume>:<fpage>1409</fpage>&#x02013;<lpage>14</lpage>.</mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lin</surname>
<given-names>C-Y</given-names>
</string-name>, <string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wu</surname><given-names>J-H</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Regulatory patterns of Crp on monensin biosynthesis in <italic toggle="yes">Streptomyces cinnamonensis</italic></article-title>. <source>Microorganisms</source>. <year>2020</year>;<volume>8</volume>:<fpage>271</fpage>.</mixed-citation></ref><ref id="bib62"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liu</surname>
<given-names>W-B</given-names>
</string-name>, <string-name><surname>Shi</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yao</surname><given-names>L-L</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Prediction and characterization of small non-coding RNAs related to secondary metabolites in <italic toggle="yes">Saccharopolyspora erythraea</italic></article-title>. <person-group person-group-type="editor"><string-name><surname>Virolle</surname><given-names>M-J</given-names></string-name></person-group> (ed.). <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>:<fpage>e80676</fpage>.<pub-id pub-id-type="pmid">24236194</pub-id></mixed-citation></ref><ref id="bib63"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lopatniuk</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Myronovskyi</surname><given-names>M</given-names></string-name>, <string-name><surname>Luzhetskyy</surname><given-names>A</given-names></string-name></person-group>. <article-title>Streptomyces albus: a new cell factory for non-canonical amino acids incorporation into ribosomally synthesized natural products</article-title>. <source>ACS Chem Biol</source>. <year>2017</year>;<volume>12</volume>:<fpage>2362</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">28758722</pub-id></mixed-citation></ref><ref id="bib64"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Luke&#x0017e;i&#x0010d;</surname>
<given-names>T</given-names>
</string-name>, <string-name><surname>Fayad</surname><given-names>AA</given-names></string-name>, <string-name><surname>Bader</surname><given-names>C</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Engineering atypical tetracycline formation in <italic toggle="yes">Amycolatopsis sulphurea</italic> for the production of modified chelocardin antibiotics</article-title>. <source>ACS Chem Biol</source>. <year>2019</year>;<volume>14</volume>:<fpage>468</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">30747520</pub-id></mixed-citation></ref><ref id="bib65"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lv</surname>
<given-names>H</given-names>
</string-name>, <string-name><surname>Li</surname><given-names>J</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Transporter and its engineering for secondary metabolites</article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2016</year>;<volume>100</volume>:<fpage>6119</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">27209041</pub-id></mixed-citation></ref><ref id="bib66"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Martens</surname>
<given-names>E</given-names>
</string-name>, <string-name><surname>Demain</surname><given-names>AL</given-names></string-name></person-group>. <article-title>The antibiotic resistance crisis, with a focus on the United States</article-title>. <source>J Antibiot (Tokyo)</source>. <year>2017</year>;<volume>70</volume>:<fpage>520</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">28246379</pub-id></mixed-citation></ref><ref id="bib68"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mart&#x000ed;nez-Trevi&#x000f1;o</surname>
<given-names>SH</given-names>
</string-name>, <string-name><surname>Uc-Cetina</surname><given-names>V</given-names></string-name>, <string-name><surname>Fern&#x000e1;ndez-Herrera</surname><given-names>MA</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Prediction of natural product classes using machine learning and 13C NMR spectroscopic data</article-title>. <source>J Chem Inf Model</source>. <year>2020</year>;<volume>60</volume>:<fpage>3376</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">32538625</pub-id></mixed-citation></ref><ref id="bib67"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mart&#x000ed;n</surname>
<given-names>JF</given-names>
</string-name>, <string-name><surname>Casqueiro</surname><given-names>J</given-names></string-name>, <string-name><surname>Liras</surname><given-names>P</given-names></string-name></person-group>. <article-title>Secretion systems for secondary metabolites: how producer cells send out messages of intercellular communication</article-title>. <source>Curr Opin Microbiol</source>. <year>2005</year>;<volume>8</volume>:<fpage>282</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">15939351</pub-id></mixed-citation></ref><ref id="bib69"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mast</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Weber</surname><given-names>T</given-names></string-name>, <string-name><surname>G&#x000f6;lz</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Characterization of the &#x02018;pristinamycin supercluster&#x02019; of <italic toggle="yes">Streptomyces pristinaespiralis</italic></article-title>. <source>Microb Biotechnol</source>. <year>2011</year>;<volume>4</volume>:<fpage>192</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="pmid">21342465</pub-id></mixed-citation></ref><ref id="bib70"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Medema</surname>
<given-names>MH</given-names>
</string-name>, <string-name><surname>Trefzer</surname><given-names>A</given-names></string-name>, <string-name><surname>Kovalchuk</surname><given-names>A</given-names></string-name><etal>et al.</etal></person-group>
<article-title>The sequence of a 1.8-Mb bacterial linear plasmid reveals a rich evolutionary reservoir of secondary metabolic pathways</article-title>. <source>Genome Biol Evolut</source>. <year>2010</year>;<volume>2</volume>:<fpage>212</fpage>&#x02013;<lpage>24</lpage>.</mixed-citation></ref><ref id="bib71"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mikul&#x000ed;k</surname>
<given-names>K</given-names>
</string-name>, <string-name><surname>Bobek</surname><given-names>J</given-names></string-name>, <string-name><surname>Z&#x000ed;dkov&#x000e1;</surname><given-names>J</given-names></string-name><etal>et al.</etal></person-group>
<article-title>6S RNA modulates growth and antibiotic production in <italic toggle="yes">Streptomyces coelicolor</italic></article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2014</year>;<volume>98</volume>:<fpage>7185</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">24859522</pub-id></mixed-citation></ref><ref id="bib72"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mitousis</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Thoma</surname><given-names>Y</given-names></string-name>, <string-name><surname>Musiol-Kroll</surname><given-names>EM</given-names></string-name></person-group>. <article-title>An update on molecular tools for genetic engineering of actinomycetes&#x02014;the source of important antibiotics and other valuable compounds</article-title>. <source>Antibiotics</source>. <year>2020</year>;<volume>9</volume>:<fpage>1</fpage>&#x02013;<lpage>31</lpage>.</mixed-citation></ref><ref id="bib73"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Musiol-Kroll</surname>
<given-names>EM</given-names>
</string-name>, <string-name><surname>Tocchetti</surname><given-names>A</given-names></string-name>, <string-name><surname>Sosio</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Challenges and advances in genetic manipulation of filamentous actinomycetes-the remarkable producers of specialized metabolites</article-title>. <source>Nat Prod Rep</source>. <year>2019</year>;<volume>36</volume>:<fpage>1351</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">31517370</pub-id></mixed-citation></ref><ref id="bib74"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nitta</surname>
<given-names>K</given-names>
</string-name>, <string-name><surname>Breitling</surname><given-names>R</given-names></string-name>, <string-name><surname>Takano</surname><given-names>E</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Investigation of the effects of actinorhodin biosynthetic gene cluster expression and a rpoB point mutation on the metabolome of <italic toggle="yes">Streptomyces coelicolor</italic> M1146</article-title>. <source>J Biosci Bioeng</source>. <year>2021</year>;<volume>131</volume>, <comment>DOI: 10.1016/j.jbiosc.2021.01.002</comment>.</mixed-citation></ref><ref id="bib75"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nitta</surname>
<given-names>K</given-names>
</string-name>, <string-name><surname>Carratore</surname><given-names>F Del</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Multi-omics analysis of the effect of cAMP on actinorhodin production in <italic toggle="yes">Streptomyces coelicolor</italic></article-title>. <source>Front Bioeng Biotechnol</source>. <year>2020</year>;<volume>8</volume>, <comment>DOI: 10.3389/fbioe.2020.595552</comment>.</mixed-citation></ref><ref id="bib76"><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Nogawa</surname>
<given-names>T</given-names>
</string-name>, <string-name><surname>Lopez</surname><given-names>JAV</given-names></string-name>, <string-name><surname>Osada</surname><given-names>H</given-names></string-name></person-group>. <source>Microbial Fraction Library: A Screening Source for Drug Discovery. Cutting-Edge Organic Synthesis and Chemical Biology of Bioactive Molecules</source>. <publisher-name>Springer</publisher-name>; <publisher-loc>Singapore</publisher-loc>, <year>2019</year>, <fpage>1</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="bib77"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Onaka</surname>
<given-names>H</given-names>
</string-name>
</person-group>. <article-title>Novel antibiotic screening methods to awaken silent or cryptic secondary metabolic pathways in actinomycetes</article-title>. <source>J Antibiot (Tokyo)</source>. <year>2017</year>;<volume>70</volume>:<fpage>865</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">28442735</pub-id></mixed-citation></ref><ref id="bib78"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Palazzotto</surname>
<given-names>E</given-names>
</string-name>, <string-name><surname>Tong</surname><given-names>Y</given-names></string-name>, <string-name><surname>Lee</surname><given-names>SY</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Synthetic biology and metabolic engineering of actinomycetes for natural product discovery</article-title>. <source>Biotechnol Adv</source>. <year>2019</year>;<volume>37</volume>:<fpage>107366</fpage>.<pub-id pub-id-type="pmid">30853630</pub-id></mixed-citation></ref><ref id="bib79"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>P&#x000e9;rez-Victoria</surname>
<given-names>I</given-names>
</string-name>, <string-name><surname>Mart&#x000ed;n</surname><given-names>J</given-names></string-name>, <string-name><surname>Reyes</surname><given-names>F</given-names></string-name></person-group>. <article-title>Combined LC/UV/MS and NMR strategies for the dereplication of marine natural products</article-title>. <source>Planta Med</source>. <year>2016</year>;<volume>82</volume>:<fpage>857</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">27002401</pub-id></mixed-citation></ref><ref id="bib80"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Petkovi&#x00107;</surname>
<given-names>H</given-names>
</string-name>, <string-name><surname>Luke&#x0017e;i&#x0010d;</surname><given-names>T</given-names></string-name>, <string-name><surname>&#x00160;u&#x00161;kovi&#x00107;</surname><given-names>J</given-names></string-name></person-group>. <article-title>Biosynthesis of oxytetracycline by <italic toggle="yes">Streptomyces rimosus</italic>: past, present and future directions in the development of tetracycline antibiotics</article-title>. <source>Food Technol Biotechnol</source>. <year>2017</year>;<volume>55</volume>:<fpage>3</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">28559729</pub-id></mixed-citation></ref><ref id="bib81"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Qiu</surname>
<given-names>J</given-names>
</string-name>, <string-name><surname>Zhuo</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>D</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Overexpression of the ABC transporter AvtAB increases avermectin production in <italic toggle="yes">Streptomyces avermitilis</italic></article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2011</year>;<volume>92</volume>:<fpage>337</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">21713508</pub-id></mixed-citation></ref><ref id="bib82"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Reher</surname>
<given-names>R</given-names>
</string-name>, <string-name><surname>Kim</surname><given-names>HW</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C</given-names></string-name><etal>et al.</etal></person-group>
<article-title>A convolutional neural network-based approach for the rapid annotation of molecularly diverse natural products</article-title>. <source>J Am Chem Soc</source>. <year>2020</year>;<volume>142</volume>:<fpage>4114</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">32045230</pub-id></mixed-citation></ref><ref id="bib83"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ren</surname>
<given-names>Q</given-names>
</string-name>, <string-name><surname>Chen</surname><given-names>K</given-names></string-name>, <string-name><surname>Paulsen</surname><given-names>IT</given-names></string-name></person-group>. <article-title>TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels</article-title>. <source>Nucleic Acids Res</source>. <year>2007</year>;<volume>35</volume>:<fpage>D274</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">17135193</pub-id></mixed-citation></ref><ref id="bib85"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Santos-Aberturas</surname>
<given-names>J</given-names>
</string-name>, <string-name><surname>Chandra</surname><given-names>G</given-names></string-name>, <string-name><surname>Frattaruolo</surname><given-names>L</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Uncovering the unexplored diversity of thioamidated ribosomal peptides in Actinobacteria using the RiPPER genome mining tool</article-title>. <source>Nucleic Acids Res</source>. <year>2019</year>;<volume>47</volume>:<fpage>4624</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">30916321</pub-id></mixed-citation></ref><ref id="bib86"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Severi</surname>
<given-names>E</given-names>
</string-name>, <string-name><surname>Thomas</surname><given-names>GH</given-names></string-name></person-group>. <article-title>Antibiotic export: transporters involved in the final step of natural product production</article-title>. <source>Microbiol (United Kingdom)</source>. <year>2019</year>;<volume>165</volume>:<fpage>805</fpage>&#x02013;<lpage>18</lpage>.</mixed-citation></ref><ref id="bib87"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Shao</surname>
<given-names>Z</given-names>
</string-name>, <string-name><surname>Rao</surname><given-names>G</given-names></string-name>, <string-name><surname>Li</surname><given-names>C</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Refactoring the silent spectinabilin gene cluster using a plug-and-play scaffold</article-title>. <source>ACS Synth Biol</source>. <year>2013</year>;<volume>2</volume>:<fpage>662</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">23968564</pub-id></mixed-citation></ref><ref id="bib88"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Simeonidis</surname>
<given-names>E</given-names>
</string-name>, <string-name><surname>Price</surname><given-names>ND</given-names></string-name></person-group>. <article-title>Genome-scale modeling for metabolic engineering</article-title>. <source>J Ind Microbiol Biotechnol</source>. <year>2015</year>;<volume>42</volume>:<fpage>327</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="pmid">25578304</pub-id></mixed-citation></ref><ref id="bib89"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Singh</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Chaudhary</surname><given-names>S</given-names></string-name>, <string-name><surname>Sareen</surname><given-names>D</given-names></string-name></person-group>. <article-title>Roseocin, a novel two-component lantibiotic from an actinomycete</article-title>. <source>Mol Microbiol</source>. <year>2020</year>;<volume>113</volume>:<fpage>326</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">31696567</pub-id></mixed-citation></ref><ref id="bib90"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Soares-Silva</surname>
<given-names>I</given-names>
</string-name>, <string-name><surname>Ribas</surname><given-names>D</given-names></string-name>, <string-name><surname>Sousa-Silva</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Membrane transporters in the bioproduction of organic acids: state of the art and future perspectives for industrial applications</article-title>. <source>FEMS Microbiol Lett</source>. <year>2020</year>;<volume>367</volume>:<fpage>118</fpage>.</mixed-citation></ref><ref id="bib91"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Song</surname>
<given-names>C</given-names>
</string-name>, <string-name><surname>Luan</surname><given-names>J</given-names></string-name>, <string-name><surname>Cui</surname><given-names>Q</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Enhanced heterologous spinosad production from a 79-kb synthetic multioperon assembly</article-title>. <source>ACS Synth Biol</source>. <year>2019</year>;<volume>8</volume>:<fpage>137</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="pmid">30590919</pub-id></mixed-citation></ref><ref id="bib92"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Springthorpe</surname>
<given-names>V</given-names>
</string-name>, <string-name><surname>Leaman</surname><given-names>R</given-names></string-name>, <string-name><surname>Sifouna</surname><given-names>D</given-names></string-name><etal>et al.</etal></person-group>
<article-title>MORF: an online tool for exploring microbial cell responses using multi-omics analysis</article-title>. <source>Access Microbiol</source>. <year>2020</year>;<volume>2</volume>:<fpage>763</fpage>.</mixed-citation></ref><ref id="bib93"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sulheim</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Kumelj</surname><given-names>T</given-names></string-name>, <string-name><surname>van&#x000a0;Dissel</surname><given-names>D</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Enzyme-constrained models and omics analysis of <italic toggle="yes">Streptomyces coelicolor</italic> reveal metabolic changes that enhance heterologous production</article-title>. <source>iScience</source>. <year>2020</year>;<volume>23</volume>:<fpage>101525</fpage>.<pub-id pub-id-type="pmid">32942174</pub-id></mixed-citation></ref><ref id="bib94"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tocchetti</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Donadio</surname><given-names>S</given-names></string-name>, <string-name><surname>Sosio</surname><given-names>M.</given-names></string-name></person-group>
<article-title>Large inserts for big data: artificial chromosomes in the genomic era</article-title>. <source>FEMS Microbiol Lett</source>. <year>2018</year>;<volume>365</volume>:<fpage>64</fpage>.</mixed-citation></ref><ref id="bib95"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Toro</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Pinilla</surname><given-names>L</given-names></string-name>, <string-name><surname>Avignone-Rossa</surname><given-names>C</given-names></string-name><etal>et al.</etal></person-group>
<article-title>An enhanced genome-scale metabolic reconstruction of <italic toggle="yes">Streptomyces clavuligerus</italic> identifies novel strain improvement strategies</article-title>. <source>Bioprocess Biosyst Eng</source>. <year>2018</year>;<volume>41</volume>:<fpage>657</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">29404683</pub-id></mixed-citation></ref><ref id="bib96"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tripathi</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>V&#x000e1;zquez-Baeza</surname><given-names>Y</given-names></string-name>, <string-name><surname>Gauglitz</surname><given-names>JM</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Chemically informed analyses of metabolomics mass spectrometry data with Qemistree</article-title>. <source>Nat Chem Biol</source>. <year>2021</year>;<volume>17</volume>:<fpage>146</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">33199911</pub-id></mixed-citation></ref><ref id="bib97"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tsigkinopoulou</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Baker</surname><given-names>SM</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R.</given-names></string-name></person-group>
<article-title>Respectful modeling: addressing uncertainty in dynamic system models for molecular biology</article-title>. <source>Trends Biotechnol</source>. <year>2017</year>;<volume>35</volume>:<fpage>518</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">28094080</pub-id></mixed-citation></ref><ref id="bib98"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tsigkinopoulou</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Hawari</surname><given-names>A</given-names></string-name>, <string-name><surname>Uttley</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Defining informative priors for ensemble modeling in systems biology</article-title>. <source>Nat Protoc</source>. <year>2018</year>;<volume>13</volume>:<fpage>2643</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">30353176</pub-id></mixed-citation></ref><ref id="bib99"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tsigkinopoulou</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Takano</surname><given-names>E</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R</given-names></string-name></person-group>. <article-title>Unravelling the &#x003b3;-butyrolactone network in <italic toggle="yes">Streptomyces coelicolor</italic> by computational ensemble modelling</article-title>. <person-group person-group-type="editor"><string-name><surname>Csik&#x000e1;sz-Nagy</surname><given-names>A</given-names></string-name></person-group> (ed.). <source>PLoS Comput Biol</source>. <year>2020</year>;<volume>16</volume>:<fpage>e1008039</fpage>.<pub-id pub-id-type="pmid">32649676</pub-id></mixed-citation></ref><ref id="bib100"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Uguru</surname>
<given-names>GC</given-names>
</string-name>, <string-name><surname>Mondhe</surname><given-names>M</given-names></string-name>, <string-name><surname>Goh</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Synthetic RNA silencing of actinorhodin biosynthesis in <italic toggle="yes">Streptomyces coelicolor</italic> A3(2)</article-title>. <person-group person-group-type="editor"><string-name><surname>Isalan</surname><given-names>M</given-names></string-name></person-group> (ed.). <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>:<fpage>e67509</fpage>.<pub-id pub-id-type="pmid">23826310</pub-id></mixed-citation></ref><ref id="bib101"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Valverde</surname>
<given-names>JR</given-names>
</string-name>, <string-name><surname>Gull&#x000f3;n</surname><given-names>S</given-names></string-name>, <string-name><surname>Mellado</surname><given-names>RP</given-names></string-name></person-group>. <article-title>Modelling the metabolism of protein secretion through the Tat route in <italic toggle="yes">Streptomyces lividans</italic></article-title>. <source>BMC Microbiol</source>. <year>2018</year>;<volume>18</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">29433435</pub-id></mixed-citation></ref><ref id="bib84"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Van&#x000a0;Santen</surname>
<given-names>JA</given-names>
</string-name>, <string-name><surname>Jacob</surname><given-names>G</given-names></string-name>, <string-name><surname>Singh</surname><given-names>AL</given-names></string-name><etal>et al.</etal></person-group>
<article-title>The natural products atlas: an open access knowledge base for microbial natural products discovery</article-title>. <source>ACS Central Sci</source>. <year>2019</year>;<volume>5</volume>:<fpage>1824</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="bib102"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name><surname>Marci&#x00161;auskas</surname><given-names>S</given-names></string-name>, <string-name><surname>S&#x000e1;nchez</surname><given-names>BJ</given-names></string-name><etal>et al.</etal></person-group>
<article-title>RAVEN 2.0: a versatile toolbox for metabolic network reconstruction and a case study on <italic toggle="yes">Streptomyces coelicolor</italic></article-title>. <source>PLoS Comput Biol</source>. <year>2018</year>;<volume>14</volume>:<fpage>e1006541</fpage>.<pub-id pub-id-type="pmid">30335785</pub-id></mixed-citation></ref><ref id="bib103"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Carver</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Phelan</surname><given-names>VV</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Sharing and community curation of mass spectrometry data with global natural products social molecular networking</article-title>. <source>Nat Biotechnol</source>. <year>2016</year>;<volume>34</volume>:<fpage>828</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">27504778</pub-id></mixed-citation></ref><ref id="bib104"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>P</given-names>
</string-name>, <string-name><surname>Bashiri</surname><given-names>G</given-names></string-name>, <string-name><surname>Gao</surname><given-names>X</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Uncovering the enzymes that catalyze the final steps in oxytetracycline biosynthesis</article-title>. <source>J Am Chem Soc</source>. <year>2013</year>;<volume>135</volume>:<fpage>7138</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">23621493</pub-id></mixed-citation></ref><ref id="bib105"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>P</given-names>
</string-name>, <string-name><surname>Kim</surname><given-names>W</given-names></string-name>, <string-name><surname>Pickens</surname><given-names>LB</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Heterologous expression and manipulation of three tetracycline biosynthetic pathways</article-title>. <source>Angew Chem</source>. <year>2012</year>;<volume>124</volume>:<fpage>11298</fpage>&#x02013;<lpage>302</lpage>.</mixed-citation></ref><ref id="bib106"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name><surname>Yin</surname><given-names>S</given-names></string-name>, <string-name><surname>Bai</surname><given-names>J</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Heterologous production of chlortetracycline in an industrial grade <italic toggle="yes">Streptomyces rimosus</italic> host</article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2019</year>;<volume>103</volume>:<fpage>6645</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">31240365</pub-id></mixed-citation></ref><ref id="bib107"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xia</surname>
<given-names>H</given-names>
</string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Li</surname><given-names>Z</given-names></string-name><etal>et al.</etal></person-group>
<article-title>The application of regulatory cascades in Streptomyces: yield enhancement and metabolite mining</article-title>. <source>Front Microbiol</source>. <year>2020</year>;<volume>11</volume>, <comment>DOI: 10.3389/fmicb.2020.00406</comment>.</mixed-citation></ref><ref id="bib108"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xu</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Wright</surname><given-names>GD.</given-names></string-name></person-group>
<article-title>Heterologous expression-facilitated natural products&#x02019; discovery in actinomycetes</article-title>. <source>J Ind Microbiol Biotechnol</source>. <year>2019</year>;<volume>46</volume>:<fpage>415</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">30446891</pub-id></mixed-citation></ref><ref id="bib109"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamanaka</surname>
<given-names>K</given-names>
</string-name>, <string-name><surname>Reynolds</surname><given-names>KA</given-names></string-name>, <string-name><surname>Kersten</surname><given-names>RD</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A</article-title>. <source>Proc Natl Acad Sci</source>. <year>2014</year>;<volume>111</volume>:<fpage>1957</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">24449899</pub-id></mixed-citation></ref><ref id="bib110"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ye</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Enghiad</surname><given-names>B</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>H</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Fine-tuning the regulation of Cas9 expression levels for efficient CRISPR-Cas9 mediated recombination in Streptomyces</article-title>. <source>J Ind Microbiol Biotechnol</source>. <year>2020</year>;<volume>47</volume>:<fpage>413</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">32367443</pub-id></mixed-citation></ref><ref id="bib111"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yin</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name><surname>Shi</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Improvement of oxytetracycline production mediated via cooperation of resistance genes in <italic toggle="yes">Streptomyces rimosus</italic></article-title>. <source>Sci Chin Life Sci</source>. <year>2017</year>;<volume>60</volume>:<fpage>992</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="bib112"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zakrzewski</surname>
<given-names>P</given-names>
</string-name>, <string-name><surname>Medema</surname><given-names>MH</given-names></string-name>, <string-name><surname>Gevorgyan</surname><given-names>A</given-names></string-name><etal>et al.</etal></person-group>
<article-title>MultiMetEval: comparative and multi-objective analysis of genome-scale metabolic models</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>, <comment>DOI: 10.1371/journal.pone.0051511</comment>.</mixed-citation></ref><ref id="bib113"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zani</surname>
<given-names>CL</given-names>
</string-name>, <string-name><surname>Carroll</surname><given-names>AR</given-names></string-name></person-group>. <article-title>Database for rapid dereplication of known natural products using data from MS and fast NMR experiments</article-title>. <source>J Nat Prod</source>. <year>2017</year>;<volume>80</volume>:<fpage>1758</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">28616931</pub-id></mixed-citation></ref><ref id="bib114"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, <string-name><surname>Zhou</surname><given-names>YT</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>SX</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Amphotericin B biosynthesis in <italic toggle="yes">Streptomyces nodosus</italic>: quantitative analysis of metabolism via LC-MS/MS based metabolomics for rational design</article-title>. <source>Microb Cell Fact</source>. <year>2020</year>;<volume>19</volume>, <comment>DOI: 10.1186/s12934-020-1290-y</comment>.</mixed-citation></ref><ref id="bib115"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname>
<given-names>JJ</given-names>
</string-name>, <string-name><surname>Tang</surname><given-names>X</given-names></string-name>, <string-name><surname>Moore</surname><given-names>BS.</given-names></string-name></person-group>
<article-title>Genetic platforms for heterologous expression of microbial natural products</article-title>. <source>Nat Prod Rep</source>. <year>2019</year>;<volume>36</volume>:<fpage>1313</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">31197291</pub-id></mixed-citation></ref><ref id="bib116"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name><surname>Zhao</surname><given-names>G</given-names></string-name>, <string-name><surname>Ding</surname><given-names>X.</given-names></string-name></person-group>
<article-title>Tandem assembly of the epothilone biosynthetic gene cluster by in vitro site-specific recombination</article-title>. <source>Sci Rep</source>. <year>2011</year>;<volume>1</volume>:<fpage>1</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">22355520</pub-id></mixed-citation></ref><ref id="bib117"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</string-name>, <string-name><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name><surname>Luo</surname><given-names>Y.</given-names></string-name></person-group>
<article-title>Recent advances in natural products exploitation in Streptomyces via synthetic biology</article-title>. <source>Eng Life Sci</source>. <year>2019</year>;<volume>19</volume>:<fpage>452</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">32625022</pub-id></mixed-citation></ref><ref id="bib118"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhou</surname>
<given-names>Q</given-names>
</string-name>, <string-name><surname>Ning</surname><given-names>S</given-names></string-name>, <string-name><surname>Luo</surname><given-names>Y.</given-names></string-name></person-group>
<article-title>Coordinated regulation for nature products discovery and overproduction in Streptomyces</article-title>. <source>Synth Syst Biotechnol</source>. <year>2020</year>;<volume>5</volume>:<fpage>49</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">32346621</pub-id></mixed-citation></ref><ref id="bib119"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</string-name>, <string-name><surname>Gu</surname><given-names>J</given-names></string-name>, <string-name><surname>Du</surname><given-names>Y-L</given-names></string-name><etal>et al.</etal></person-group>
<article-title>The -omics era- toward a systems-level understanding of Streptomyces</article-title>. <source>Curr Genomics</source>. <year>2011</year>;<volume>12</volume>:<fpage>404</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">22379394</pub-id></mixed-citation></ref><ref id="bib120"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</string-name>, <string-name><surname>Sun</surname><given-names>N</given-names></string-name>, <string-name><surname>Wu</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group>
<article-title>Genomic data mining reveals a rich repertoire of transport proteins in Streptomyces</article-title>. <source>BMC Genomics</source>. <year>2016</year>;<volume>17</volume>:<fpage>510</fpage>.<pub-id pub-id-type="pmid">27557108</pub-id></mixed-citation></ref></ref-list></back></article>